Lighthouse Investment Partners’s Edwards Lifesciences EW Stock Holding History

Lighthouse Investment Partners’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,148	Closed	-$252K	–	797
2026 Q1	$252K	Buy	+3,148	New	+$260K	0.01%	615
2025 Q3	–	Sell	-31,300	Closed	-$2.45M	–	675
2025 Q2	$2.45M	Buy	+31,300	New	+$2.33M	0.09%	271
2025 Q1	–	Sell	-43,500	Closed	-$3.22M	–	532
2024 Q4	$3.22M	Buy	43,500 +13,500	+45%	+$945K	0.11%	226
2024 Q3	$1.98M	Sell	30,000 -77,504	-72%	-$5.63M	0.07%	262
2024 Q2	$9.93M	Buy	107,504 +79,952	+290%	+$7.08M	0.4%	64
2024 Q1	$2.63M	Sell	27,552 -29,199	-51%	-$2.45M	0.12%	199
2023 Q4	$4.33M	Buy	+56,751	New	+$3.95M	0.2%	123

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Lighthouse Investment Partners's EW Position: Q2 2026 in Review

Lighthouse Investment Partners sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 3,148 shares — an estimated $252K sold.

Lighthouse Investment Partners first reported a position in EW in Q4 2023 and held it in 7 quarters. The position peaked at $9.93M in Q2 2024. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Lighthouse Investment Partners reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
Lighthouse Investment Partners sold 3,148 Edwards Lifesciences shares in Q2 2026, an estimated $252K.
Lighthouse Investment Partners first reported a position in Edwards Lifesciences in Q4 2023 and held it in 7 quarters.
Lighthouse Investment Partners's Edwards Lifesciences position peaked at $9.93M in Q2 2024.
1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Lighthouse Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.